Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time periodHiba Dagher, Issam Raad, Daniel D. Karp et al.|eLife|2023Cited by 42
Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell TransplantHiba Dagher, Issam Raad, Ray Hachem et al.|Journal of Fungi|2022Cited by 26
The role of procalcitonin in identifying high‐risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer scorePatrick Chaftari, Issam Raad, Anne‐Marie Chaftari et al.|Cancer Medicine|2021Cited by 20
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorshipIssam Raad, Dimitrios P. Kontoyiannis, Ray Hachem et al.|eLife|2023Cited by 18
A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropeniaAnne‐Marie Chaftari, Issam Raad, Hiba Dagher et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 11